abstract |
In the present invention, compounds of the following formula are described, methods for their preparation, pharmaceutical compositions containing them, and their use in therapy. The compounds of the present invention inhibit IAP (an inhibitor of apoptotic proteins) and are therefore useful in the treatment of cancer, autoimmune diseases, and other disorders involving defects in apoptosis. |